Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy

Diabetic retinopathy (DR) is one of the most common microvascular complications of diabetes and is the leading cause of blindness in young adults. Oxidative stress has been implicated as a critical cause of DR. Metabolic abnormalities induced by high-glucose levels are involved in the development of DR and appear to be influenced by oxidative stress. The imbalance between reactive oxygen species (ROS) production and the antioxidant defense system activates several oxidative stress-related mechanisms that promote the pathogenesis of DR. The damage caused by oxidative stress persists for a considerable time, even after the blood glucose concentration has returned to a normal level. Animal experiments have proved that the use of antioxidants is a beneficial therapeutic strategy for the treatment of DR, but more data are required from clinical trials. The aims of this review are to highlight the improvements to our understanding of the oxidative stress-related mechanisms underlying the development of DR and provide a summary of the main antioxidant therapy strategies used to treat the disease.

[1]  Guoxin Zhang,et al.  Helicobacter pylori modulates cisplatin sensitivity in gastric cancer by down‐regulating miR‐141 expression , 2017, Helicobacter.

[2]  Juan Wang,et al.  The glucagon like peptide 1 analogue, exendin-4, attenuates oxidative stress-induced retinal cell death in early diabetic rats through promoting Sirt1 and Sirt3 expression. , 2016, Experimental eye research.

[3]  M. Mishra,et al.  Dynamic DNA methylation of matrix metalloproteinase-9 in the development of diabetic retinopathy , 2016, Laboratory Investigation.

[4]  Nam-Han Cho,et al.  Q&A: Five questions on the 2015 IDF Diabetes Atlas. , 2016, Diabetes research and clinical practice.

[5]  G. Jena,et al.  Role of Zinc Supplementation in Testicular and Epididymal Damages in Diabetic Rat: Involvement of Nrf2, SOD1, and GPX5 , 2016, Biological Trace Element Research.

[6]  L. Sánchez-Lozada,et al.  Anti-Inflammatory Therapy Modulates Nrf2-Keap1 in Kidney from Rats with Diabetes , 2016, Oxidative medicine and cellular longevity.

[7]  W. Choi,et al.  Increased O-GlcNAcylation of NF-κB Enhances Retinal Ganglion Cell Death in Streptozotocin-induced Diabetic Retinopathy , 2016, Current eye research.

[8]  Ming-jun Wang,et al.  High glucose induces renal tubular epithelial injury via Sirt1/NF-kappaB/microR-29/Keap1 signal pathway , 2015, Journal of Translational Medicine.

[9]  Min Young Lee,et al.  PRMT1 and PRMT4 Regulate Oxidative Stress-Induced Retinal Pigment Epithelial Cell Damage in SIRT1-Dependent and SIRT1-Independent Manners , 2015, Oxidative medicine and cellular longevity.

[10]  N. Wang,et al.  Fenofibrate suppresses cellular metabolic memory of high glucose in diabetic retinopathy via a sirtuin 1-dependent signalling pathway. , 2015, Molecular medicine reports.

[11]  A. Kowluru,et al.  Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy , 2015, Progress in Retinal and Eye Research.

[12]  M. Mishra,et al.  Epigenetic Modification of Mitochondrial DNA in the Development of Diabetic Retinopathy. , 2015, Investigative ophthalmology & visual science.

[13]  L. Cai,et al.  Potential drugs which activate nuclear factor E2-related factor 2 signaling to prevent diabetic cardiovascular complications: A focus on fumaric acid esters. , 2015, Life sciences.

[14]  A. Giovane,et al.  Sirtuins in vascular diseases: Emerging roles and therapeutic potential. , 2015, Biochimica et biophysica acta.

[15]  C. Meyer,et al.  Nitric oxide and oxidative stress is associated with severity of diabetic retinopathy and retinal structural alterations , 2015, Clinical & experimental ophthalmology.

[16]  F. Das,et al.  High glucose enhances microRNA-26a to activate mTORC1 for mesangial cell hypertrophy and matrix protein expression. , 2015, Cellular signalling.

[17]  D. Mauricio,et al.  Vitamin D Deficiency Is Associated with the Presence and Severity of Diabetic Retinopathy in Type 2 Diabetes Mellitus , 2015, Journal of diabetes research.

[18]  S. Yoshida,et al.  Increased vitreous concentrations of MCP-1 and IL-6 after vitrectomy in patients with proliferative diabetic retinopathy: possible association with postoperative macular oedema , 2015, British Journal of Ophthalmology.

[19]  T. Kundu,et al.  High-glucose-induced CARM1 expression regulates apoptosis of human retinal pigment epithelial cells via histone 3 arginine 17 dimethylation: role in diabetic retinopathy. , 2014, Archives of biochemistry and biophysics.

[20]  M. Mishra,et al.  Epigenetic modifications of Keap1 regulate its interaction with the protective factor Nrf2 in the development of diabetic retinopathy. , 2014, Investigative ophthalmology & visual science.

[21]  M. Mishra,et al.  Epigenetic modifications of Nrf2-mediated glutamate-cysteine ligase: implications for the development of diabetic retinopathy and the metabolic memory phenomenon associated with its continued progression. , 2014, Free radical biology & medicine.

[22]  M. Sarras,et al.  Parp Inhibition Prevents Ten-Eleven Translocase Enzyme Activation and Hyperglycemia-Induced DNA Demethylation , 2014, Diabetes.

[23]  P. Jagodziński,et al.  Role of epigenetic mechanisms in the development of chronic complications of diabetes. , 2014, Diabetes research and clinical practice.

[24]  M. Gomes,et al.  Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases , 2014, Diabetology & Metabolic Syndrome.

[25]  Guoxin Zhang,et al.  Helicobacter pylori Modulates Cisplatin Sensitivity in Gastric Cancer by Down‐Regulating miR‐141 Expression , 2014, Helicobacter.

[26]  Dong Hoon Lee,et al.  Tonicity-responsive enhancer binding protein regulates the expression of aldose reductase and protein kinase C δ in a mouse model of diabetic retinopathy. , 2014, Experimental eye research.

[27]  Yue Yang,et al.  Association of tea consumption and the risk of oral cancer: a meta-analysis. , 2014, Oral oncology.

[28]  P. Chandler,et al.  Requirement of NOX2 Expression in Both Retina and Bone Marrow for Diabetes-Induced Retinal Vascular Injury , 2013, PloS one.

[29]  M. Mishra,et al.  Epigenetic Modifications and Diabetic Retinopathy , 2013, BioMed research international.

[30]  David A. Johnson,et al.  Regulation of SIRT1 by oxidative stress-responsive miRNAs and a systematic approach to identify its role in the endothelium. , 2013, Antioxidants & redox signaling.

[31]  K. Palczewski,et al.  Photoreceptor cells are major contributors to diabetes-induced oxidative stress and local inflammation in the retina , 2013, Proceedings of the National Academy of Sciences.

[32]  Zhi-Min Liu,et al.  Resveratrol Protects Vascular Endothelial Cells from High Glucose–Induced Apoptosis through Inhibition of NADPH Oxidase Activation–Driven Oxidative Stress , 2013, CNS neuroscience & therapeutics.

[33]  Xiangru Xu,et al.  Ten-eleven translocation (Tet) and thymine DNA glycosylase (TDG), components of the demethylation pathway, are direct targets of miRNA-29a. , 2013, Biochemical and biophysical research communications.

[34]  R. Kowluru,et al.  Regulation of Matrix Metalloproteinase-9 by Epigenetic Modifications and the Development of Diabetic Retinopathy , 2013, Diabetes.

[35]  M. Mishra,et al.  Transcription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathy. , 2013, Investigative ophthalmology & visual science.

[36]  D. Sinclair,et al.  Identification of a SIRT1 mutation in a family with type 1 diabetes. , 2013, Cell metabolism.

[37]  K. Zhou,et al.  MicroRNA-200b downregulates oxidation resistance 1 (Oxr1) expression in the retina of type 1 diabetes model. , 2013, Investigative ophthalmology & visual science.

[38]  R. Kowluru,et al.  Epigenetic modification of Sod2 in the development of diabetic retinopathy and in the metabolic memory: role of histone methylation. , 2013, Investigative ophthalmology & visual science.

[39]  E. Chaum,et al.  Age-related susceptibility to apoptosis in human retinal pigment epithelial cells is triggered by disruption of p53-Mdm2 association. , 2012, Investigative Ophthalmology and Visual Science.

[40]  Z. Ren,et al.  The impact of 1,25-dihydroxy vitamin D3 on the expressions of vascular endothelial growth factor and transforming growth factor-β₁ in the retinas of rats with diabetes. , 2012, Diabetes research and clinical practice.

[41]  Xiao-shuang Li,et al.  A possible gene silencing mechanism: hypermethylation of the Keap1 promoter abrogates binding of the transcription factor Sp1 in lung cancer cells. , 2012, Biochemical and biophysical research communications.

[42]  R. Kowluru,et al.  A compensatory mechanism protects retinal mitochondria from initial insult in diabetic retinopathy. , 2012, Free radical biology & medicine.

[43]  Jiaweng Fan,et al.  Pharmacologic induction of heme oxygenase-1 plays a protective role in diabetic retinopathy in rats. , 2012, Investigative ophthalmology & visual science.

[44]  N. Congdon,et al.  The worldwide epidemic of diabetic retinopathy , 2012, Indian journal of ophthalmology.

[45]  R. Kowluru,et al.  Mitochondria DNA replication and DNA methylation in the metabolic memory associated with continued progression of diabetic retinopathy. , 2012, Investigative ophthalmology & visual science.

[46]  M. Sarras,et al.  Metabolic Memory and Chronic Diabetes Complications: Potential Role for Epigenetic Mechanisms , 2012, Current Diabetes Reports.

[47]  Onju Ham,et al.  Up-regulation of miR-26a promotes apoptosis of hypoxic rat neonatal cardiomyocytes by repressing GSK-3β protein expression. , 2012, Biochemical and biophysical research communications.

[48]  Y. Lee,et al.  Methylglyoxal induces hyperpermeability of the blood–retinal barrier via the loss of tight junction proteins and the activation of matrix metalloproteinases , 2012, Graefe's Archive for Clinical and Experimental Ophthalmology.

[49]  Ying He,et al.  Sirtuin 1–Mediated Cellular Metabolic Memory of High Glucose Via the LKB1/AMPK/ROS Pathway and Therapeutic Effects of Metformin , 2011, Diabetes.

[50]  I. Laher,et al.  Diabetes and Alpha Lipoic Acid , 2011, Front. Pharmacol..

[51]  K. Tsubota,et al.  Roles of AMP-activated protein kinase in diabetes-induced retinal inflammation. , 2011, Investigative ophthalmology & visual science.

[52]  E. Buckles,et al.  Aberrant DNA Methylation and Prostate Cancer , 2011, Current genomics.

[53]  S. Gupta,et al.  Green Tea Prevents Hyperglycemia-Induced Retinal Oxidative Stress and Inflammation in Streptozotocin-Induced Diabetic Rats , 2011, Ophthalmic Research.

[54]  Qun Zhou,et al.  miR-200a Regulates Nrf2 Activation by Targeting Keap1 mRNA in Breast Cancer Cells* , 2011, The Journal of Biological Chemistry.

[55]  Enxuan Jing,et al.  Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production , 2011, Proceedings of the National Academy of Sciences.

[56]  T. Kitazono,et al.  Pathophysiological roles of NADPH oxidase/nox family proteins in the vascular system. -Review and perspective-. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[57]  M. Sporn,et al.  Nrf2 has a protective role against neuronal and capillary degeneration in retinal ischemia-reperfusion injury. , 2011, Free radical biology & medicine.

[58]  A. Bird,et al.  CpG islands and the regulation of transcription. , 2011, Genes & development.

[59]  S. Devaraj,et al.  Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin. , 2011, The Journal of nutritional biochemistry.

[60]  E. Şenateş,et al.  SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease , 2011, Medical science monitor : international medical journal of experimental and clinical research.

[61]  I. G. Fantus,et al.  Oltipraz upregulates the nuclear respiratory factor 2 alpha subunit (NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice , 2011, Diabetologia.

[62]  G. Mohammad,et al.  The role of Raf-1 kinase in diabetic retinopathy , 2011, Expert opinion on therapeutic targets.

[63]  Alan W. Stitt AGEs and diabetic retinopathy. , 2010, Investigative ophthalmology & visual science.

[64]  M. Mayr,et al.  Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes , 2010, Circulation research.

[65]  S. Madsen-Bouterse,et al.  Role of mitochondrial DNA damage in the development of diabetic retinopathy, and the metabolic memory phenomenon associated with its progression. , 2010, Antioxidants & redox signaling.

[66]  C. Croce,et al.  Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD. , 2010, Carcinogenesis.

[67]  A. Malik,et al.  Role of protein kinase Czeta in thrombin-induced RhoA activation and inter-endothelial gap formation of human dermal microvessel endothelial cell monolayers. , 2010, Microvascular research.

[68]  R. Kowluru,et al.  Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon , 2010, Journal of cellular biochemistry.

[69]  D. Antonetti,et al.  TNF-α Signals Through PKCζ/NF-κB to Alter the Tight Junction Complex and Increase Retinal Endothelial Cell Permeability , 2010, Diabetes.

[70]  R. Kowluru Role of matrix metalloproteinase-9 in the development of diabetic retinopathy and its regulation by H-Ras. , 2010, Investigative ophthalmology & visual science.

[71]  J. B. Lopes de Faria,et al.  Exogenous SOD mimetic tempol ameliorates the early retinal changes reestablishing the redox status in diabetic hypertensive rats. , 2010, Investigative ophthalmology & visual science.

[72]  J. Burgess,et al.  The role of vitamin E and oxidative stress in diabetes complications , 2010, Mechanisms of Ageing and Development.

[73]  M. Hayden,et al.  Calcific uremic arteriolopathy , 2010, Oxidative medicine and cellular longevity.

[74]  T. Terasaki,et al.  Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions , 2009, Journal of cellular physiology.

[75]  Elena Berrone,et al.  Thiamine and benfotiamine prevent apoptosis induced by high glucose‐conditioned extracellular matrix in human retinal pericytes , 2009, Diabetes/metabolism research and reviews.

[76]  R. Kowluru,et al.  Translocation of H-Ras and its implications in the development of diabetic retinopathy. , 2009, Biochemical and biophysical research communications.

[77]  R. Chen,et al.  Regulation of Hypoxia-Inducible Factor 2α Signaling by the Stress-Responsive Deacetylase Sirtuin 1 , 2009, Science.

[78]  R. Dahiya,et al.  BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. , 2009, Carcinogenesis.

[79]  Yingbin Ge,et al.  p38MAPK and ERK promote nitric oxide production in cultured human retinal pigmented epithelial cells induced by high concentration glucose. , 2009, Nitric oxide : biology and chemistry.

[80]  Ji‐Hyun Lee,et al.  Overexpression of SIRT1 Protects Pancreatic β-Cells Against Cytokine Toxicity by Suppressing the Nuclear Factor-κB Signaling Pathway , 2009, Diabetes.

[81]  Kyung-Chul Choi,et al.  Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. , 2009, Cancer research.

[82]  A. Hafezi-Moghadam,et al.  Rho Kinase Inhibition by Fasudil Ameliorates Diabetes-Induced Microvascular Damage , 2009, Diabetes.

[83]  R. Kowluru,et al.  Diabetes regulates small molecular weight G-protein, H-Ras, in the microvasculature of the retina: implication in the development of retinopathy. , 2008, Microvascular research.

[84]  S. Chakrabarti,et al.  PARP activation and the alteration of vasoactive factors and extracellular matrix protein in retina and kidney in diabetes , 2008, Diabetes/metabolism research and reviews.

[85]  M. Cooper,et al.  Hyperglycemia Induces a Dynamic Cooperativity of Histone Methylase and Demethylase Enzymes Associated With Gene-Activating Epigenetic Marks That Coexist on the Lysine Tail , 2008, Diabetes.

[86]  E. Araki,et al.  Endothelial MnSOD overexpression prevents retinal VEGF expression in diabetic mice. , 2008, Biochemical and biophysical research communications.

[87]  P. Dodson,et al.  PKC inhibition and diabetic microvascular complications. , 2007, Best practice & research. Clinical endocrinology & metabolism.

[88]  J. Forrester,et al.  Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. , 2007, Investigative ophthalmology & visual science.

[89]  H. Hammes,et al.  High Glucose Increases Angiopoietin-2 Transcription in Microvascular Endothelial Cells through Methylglyoxal Modification of mSin3A* , 2007, Journal of Biological Chemistry.

[90]  P. Suryanarayana,et al.  Effect of curcumin on hyperglycemia-induced vascular endothelial growth factor expression in streptozotocin-induced diabetic rat retina. , 2007, Biochemical and biophysical research communications.

[91]  C. Triggle,et al.  Oxidative stress and increased eNOS and NADPH oxidase expression in mouse microvessel endothelial cells , 2007, Journal of cellular physiology.

[92]  Csaba Szabó,et al.  Peroxynitrite: biochemistry, pathophysiology and development of therapeutics , 2007, Nature Reviews Drug Discovery.

[93]  N. Kasetsuwan,et al.  Long-term effects of oral vitamin C supplementation on the endothelial dysfunction in the iris microvessels of diabetic rats. , 2007, Microvascular research.

[94]  A. Riggs,et al.  Genome-wide Analysis of Histone Lysine Methylation Variations Caused by Diabetic Conditions in Human Monocytes* , 2007, Journal of Biological Chemistry.

[95]  R. Kowluru,et al.  Increased oxidative stress in diabetes regulates activation of a small molecular weight G-protein, H-Ras, in the retina , 2007, Molecular vision.

[96]  Renu A. Kowluru,et al.  Oxidative Stress and Diabetic Retinopathy , 2007, Experimental diabetes research.

[97]  T. Kouzarides Chromatin Modifications and Their Function , 2007, Cell.

[98]  Suzanne Schubbert,et al.  Deregulated Ras signaling in developmental disorders: new tricks for an old dog. , 2007, Current opinion in genetics & development.

[99]  Shyam Biswal,et al.  Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. , 2007, Annual review of pharmacology and toxicology.

[100]  Alan W. Stitt,et al.  Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration. , 2006, Investigative ophthalmology & visual science.

[101]  Mi-Sung Kim,et al.  H‐Ras selectively up‐regulates MMP‐9 and COX‐2 through activation of ERK1/2 and NF‐κB: An implication for invasive phenotype in rat liver epithelial cells , 2006, International journal of cancer.

[102]  Ye Xiong,et al.  Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress. , 2006, Free radical biology & medicine.

[103]  Y. M. Lee,et al.  Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1. , 2006, Oncology reports.

[104]  Ann Marie Schmidt,et al.  Advanced glycation end products: sparking the development of diabetic vascular injury. , 2006, Circulation.

[105]  A. Yoshimura,et al.  Pigment Epithelium-derived Factor Inhibits Advanced Glycation End Product-induced Retinal Vascular Hyperpermeability by Blocking Reactive Oxygen Species-mediated Vascular Endothelial Growth Factor Expression* , 2006, Journal of Biological Chemistry.

[106]  Q. Ma,et al.  Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2. , 2006, The American journal of pathology.

[107]  M. Brownlee,et al.  Effect of R-(+)-α-lipoic acid on experimental diabetic retinopathy , 2006, Diabetologia.

[108]  Cyrus Martin,et al.  The diverse functions of histone lysine methylation , 2005, Nature Reviews Molecular Cell Biology.

[109]  Rui Bernardes,et al.  Nonproliferative retinopathy in diabetes type 2. Initial stages and characterization of phenotypes , 2005, Progress in Retinal and Eye Research.

[110]  M. Tanito,et al.  Sulforaphane induces thioredoxin through the antioxidant-responsive element and attenuates retinal light damage in mice. , 2005, Investigative ophthalmology & visual science.

[111]  C. Szabó,et al.  Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. , 2005, Current medicinal chemistry.

[112]  A. Hays,et al.  Apoptosis and Cell Proliferation in Proliferative Retinal Disorders: PCNA, Ki-67, Caspase-3, and PARP Expression , 2005, Current eye research.

[113]  S. Moustafa Zinc might protect oxidative changes in the retina and pancreas at the early stage of diabetic rats. , 2004, Toxicology and applied pharmacology.

[114]  Jaetaek Kim Pericytes and the prevention of diabetic retinopathy. , 2004, Diabetes research and clinical practice.

[115]  Y. Hata,et al.  The involvement of the rho-kinase pathway and its regulation in cytokine-induced collagen gel contraction by hyalocytes. , 2004, Investigative ophthalmology & visual science.

[116]  C. Szabó,et al.  Poly(ADP-Ribose) Polymerase Is Involved in the Development of Diabetic Retinopathy via Regulation of Nuclear Factor-κB , 2004 .

[117]  D. Mcmaster,et al.  High glucose mediates pro‐oxidant and antioxidant enzyme activities in coronary endothelial cells , 2004, Diabetes, obesity & metabolism.

[118]  S. Resnikoff,et al.  Global data on visual impairment in the year 2002. , 2004, Bulletin of the World Health Organization.

[119]  A. Kowluru,et al.  Potential contributory role of H-Ras, a small G-protein, in the development of retinopathy in diabetic rats. , 2004, Diabetes.

[120]  D. Senger,et al.  Rho activity critically and selectively regulates endothelial cell organization during angiogenesis , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[121]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[122]  P. Vincent,et al.  Activated Ras induces a proangiogenic phenotype in primary endothelial cells , 2004, Oncogene.

[123]  T. Kern,et al.  Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. , 2003, Free radical biology & medicine.

[124]  L. Rossetti,et al.  Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. , 2003, The Journal of clinical investigation.

[125]  A. Shah,et al.  ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. , 2003, Journal of the American Society of Nephrology : JASN.

[126]  R. Caldwell,et al.  High glucose-induced tyrosine nitration in endothelial cells: role of eNOS uncoupling and aldose reductase activation. , 2003, Investigative ophthalmology & visual science.

[127]  D. Dykxhoorn,et al.  Killing the messenger: short RNAs that silence gene expression , 2003, Nature Reviews Molecular Cell Biology.

[128]  Sayon Roy,et al.  Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats. , 2003, Diabetes.

[129]  H. Hammes,et al.  Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy , 2003, Nature Medicine.

[130]  S. Chakrabarti,et al.  Diabetes-induced Activation of Nuclear Transcriptional Factor in the Retina, and its Inhibition by Antioxidants , 2003, Free radical research.

[131]  G. Cuda,et al.  Protection of Human Endothelial Cells From Oxidative Stress: Role of Ras-ERK1/2 Signaling , 2002, Circulation.

[132]  L. Aiello,et al.  Characterization of protein kinase C β isoform's action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[133]  R. Kowluru,et al.  Diabetes-induced Activation of Caspase-3 in Retina: Effect of Antioxidant Therapy , 2002, Free radical research.

[134]  S. Liu,et al.  Reactive oxygen species mediate cyclic strain-induced endothelin-1 gene expression via Ras/Raf/extracellular signal-regulated kinase pathway in endothelial cells. , 2001, Journal of molecular and cellular cardiology.

[135]  S. Melov,et al.  Mitochondrial DNA mutations, oxidative stress, and aging , 2001, Mechanisms of Ageing and Development.

[136]  D. Kass,et al.  Improved Arterial Compliance by a Novel Advanced Glycation End-Product Crosslink Breaker , 2001, Circulation.

[137]  G. Arden,et al.  The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment , 2001, The British journal of ophthalmology.

[138]  B. Rosner,et al.  Serum markers of oxidative stress and severity of diabetic retinopathy. , 2000, Diabetes care.

[139]  A. Das,et al.  Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor. , 1999, Archives of ophthalmology.

[140]  G. Arden,et al.  Does dark adaptation exacerbate diabetic retinopathy? Evidence and a linking hypothesis , 1998, Vision Research.

[141]  R. Klebe,et al.  Overview of matrix metalloproteinase expression in cultured human cells. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[142]  H. Hammes,et al.  Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine , 1997, Diabetologia.

[143]  J. Zweier,et al.  Mitogenic Signaling Mediated by Oxidants in Ras-Transformed Fibroblasts , 1997, Science.

[144]  I. Goldstein,et al.  Nitric Oxide: A Review of Its Role in Retinal Function and Disease , 1996, Vision Research.

[145]  S. Bursell,et al.  Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. , 1995, The American journal of physiology.

[146]  D. Cogan,et al.  NIH conference. Aldose reductase and complications of diabetes. , 1984, Annals of internal medicine.

[147]  V. Kagan,et al.  Light-induced free radical oxidation of membrane lipids in photoreceptors of frog retina. , 1973, Biochimica et Biophysica Acta.

[148]  K. Gabbay The sorbitol pathway and the complications of diabetes. , 1973, The New England journal of medicine.

[149]  N. Lopes,et al.  Polyphenol-enriched cocoa protects the diabetic retina from glial reaction through the sirtuin pathway. , 2015, The Journal of nutritional biochemistry.

[150]  B. Berkowitz,et al.  Oxidative stress and light-evoked responses of the posterior segment in a mouse model of diabetic retinopathy. , 2015, Investigative ophthalmology & visual science.

[151]  P. Humphries,et al.  Antioxidant therapy for retinal disease. , 2014, Advances in experimental medicine and biology.

[152]  S. Biswal,et al.  NRF2 plays a protective role in diabetic retinopathy in mice , 2013, Diabetologia.

[153]  Dhiren P. Shah,et al.  ON OXIDATIVE STRESS AND DIABETIC COMPLICATIONS , 2013 .

[154]  E. Schleicher,et al.  Chemistry and pathobiology of advanced glycation end products. , 2001, Contributions to nephrology.

[155]  K. Kaibuchi,et al.  Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. , 2001, Trends in pharmacological sciences.

[156]  T. Sano,et al.  [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[157]  K. Kaibuchi,et al.  Small GTP-binding proteins. , 1992, International review of cytology.

[158]  J. Stull,et al.  The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. , 1985, Annual review of pharmacology and toxicology.